Hyperfine News

Hyperfine | 10-Q: Quarterly report

SEC announcement04:06 · Announcements

Earnings Call Summary | Hyperfine(HYPR.US) Q1 2024 Earnings Conference

The following is a summary of the Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript:Financial Performance:Hyperfine, Inc. reported a Q1 2024 revenue of $3.3 million, marking a 25% growth from th

Futu NewsMay 14 18:49 · Conference Call

Hyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges

Yahoo FinanceMay 14 15:04

Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 14 07:24

Hyperfine GAAP EPS of -$0.14, Revenue of $3.3M

Seeking AlphaMay 14 05:22

Hyperfine Expects FY24 Revenue To Be $12M-$15M, Est $12.787M

Management expects cash burn for the full year 2024 to be approximately $40 million.

BenzingaMay 14 04:59

Hyperfine Q1 2024 GAAP EPS $(0.14) Beats $(0.15) Estimate, Sales $3.295M Beat $3.053M Estimate

Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 17.65 percent increase over losses of $(0.17) per

BenzingaMay 14 04:50

Hyperfine Sold 13 Commercial Swoop Systems in 1Q >HYPR

Hyperfine Sold 13 Commercial Swoop Systems in 1Q >HYPR

Dow JonesMay 14 04:08

Hyperfine 1Q Sales $3.3M >HYPR

Hyperfine 1Q Sales $3.3M >HYPR

Dow JonesMay 14 04:07

Earnings Flash (HYPR) HYPERFINE Posts Q1 Revenue $3.3M, Vs. Street Est of $3.1M

04:06 PM EDT, 05/13/2024 (MT Newswires) -- Earnings Flash (HYPR) HYPERFINE Posts Q1 Revenue $3.3M, vs. Street Est of $3.1M

MT NewswiresMay 14 04:06

Press Release: Hyperfine, Inc. Reports First Quarter 2024 Financial Results

Hyperfine, Inc. Reports First Quarter 2024 Financial Results GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has re

Dow JonesMay 14 04:05

Hyperfine Enters Agreements With Distributors In France, UK And Italy

Hyperfine Enters Agreements With Distributors In France, UK And Italy

BenzingaMay 10 21:02

Hyperfine, Inc. to Expand Global Market Reach With Appointment of International Distributors in Key European Markets

- Distributors appointed in France, the United Kingdom, and Italy - Industry veteran Enrico Barini joins as International Business Development Director Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health

BusinesswireMay 10 21:00

Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024

Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today

BusinesswireApr 30 04:05

Hyperfine Announced The Acceptance Of Seventeen Ultra-low-field MRI-related Abstracts To Be Presented At The 2024 International Society For Magnetic Resonance In Medicine Annual Meeting In Singapore

Hyperfine Announced The Acceptance Of Seventeen Ultra-low-field MRI-related Abstracts To Be Presented At The 2024 International Society For Magnetic Resonance In Medicine Annual Meeting In Singapore

BenzingaApr 23 21:06

Hyperfine, Inc. Takes the Stage at ISMRM With Seventeen Abstracts Assessing the Potential of Using Swoop System Images Across Multiple Care Settings and Clinical Conditions

Data on the company's portable MR imaging system show it can acquire brain images at the point of care that may assist physicians with screening and monitoring for Alzheimer's and multiple sclerosis b

BusinesswireApr 23 21:00

Hyperfine Enrolls First Alzheimer's Patients Receiving Amyloid-Targeting Therapy In CARE PMR Study

Study will assess the clinical utility and workflow benefits of physicians using images acquired by the Swoop Portable MR Imaging system to identify ARIA events in Alzheimer's patients treated with am

BenzingaApr 17 21:05

Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today announced that the first patients have been enrolled in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study.

BusinesswireApr 17 21:00

SEC Baby Shelf Rules Stunt Hyperfine Inc.'s Fundraising Flexibility

TipRanksMar 24 14:02

Hyperfine Price Target Cut to $1.60/Share From $2.10 by Wells Fargo

Hyperfine Price Target Cut to $1.60/Share From $2.10 by Wells Fargo

Dow JonesMar 22 23:34